{"id":10868,"date":"2022-08-31T13:13:43","date_gmt":"2022-08-31T13:13:43","guid":{"rendered":"https:\/\/www.tender-lederberg.94-130-216-58.plesk.page\/285-2\/"},"modified":"2024-12-18T13:52:32","modified_gmt":"2024-12-18T13:52:32","slug":"285-2","status":"publish","type":"post","link":"https:\/\/www.af-net.eu\/en\/285-2\/","title":{"rendered":"Better therapy for patients with heart failure and atrial fibrillation (CABA-HFPEF-DZHK27 trial)"},"content":{"rendered":"\n
\n
\n
Posts<\/h5>

NEWS<\/strong><\/h1>\n <\/div>\n <\/div>\n\n\n\n
<\/div>\n\n\n\n

Wed, 31.08.2022<\/p>\n\n\n\n

Better therapy for patients with heart failure and atrial fibrillation (CABA-HFPEF-DZHK27 trial)<\/h3>\n\n\n\n

The study “CABA-HFPEF-DZHK27” (CA<\/strong>theter-B<\/strong>ased\u00a0A<\/strong>blation of atrial fibrillation vs. conventional treatment in patients with\u00a0H<\/strong>eart\u00a0F<\/strong>ailure with\u00a0P<\/strong>reserved\u00a0E<\/strong>jection\u00a0F<\/strong>raction) is aiming for\u00a0a better therapy for\u00a0patients with heart failure and atrial fibrillation. Charit\u00e9 (Berlin, Germany) has the overall responsibility\u00a0for the study. This trial is supported by German Centre for Cardiovascular Research\u00a0(DZHK). Further information can be found in the\u00a0press release<\/a>\u00a0(german only).\u00a0<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

The study “CABA-HFPEF-DZHK27” (CAtheter-Based\u00a0Ablation of atrial fibrillation vs. conventional treatment in patients with\u00a0Heart\u00a0Failure with\u00a0Preserved\u00a0Ejection\u00a0Fraction) is aiming for\u00a0a better therapy for\u00a0patients with heart failure and atrial fibrillation. Charit\u00e9 (Berlin, Germany) has the overall responsibility\u00a0for the study. This trial is supported by German Centre for Cardiovascular Research\u00a0(DZHK). Further information can be found in the\u00a0press release\u00a0(german only).\u00a0<\/p>\n","protected":false},"author":1,"featured_media":11773,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","iawp_total_views":8,"_vp_format_video_url":"","_vp_image_focal_point":[],"footnotes":""},"categories":[19,21,1],"tags":[],"class_list":["post-10868","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-2","category-news-en","category-unkategorisiert"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"thumbnail":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31-150x150.png",150,150,true],"medium":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31-300x124.png",300,124,true],"medium_large":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"large":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"timeline-express":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31-350x120.png",350,120,true],"timeline-express-thumbnail":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31-200x120.png",200,120,true],"1536x1536":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"2048x2048":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"vp_sm":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"vp_md":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"vp_lg":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"vp_xl":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"vp_sm_popup":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"vp_md_popup":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false],"vp_xl_popup":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/08\/2022_August_31.png",398,164,false]},"uagb_author_info":{"display_name":"admin","author_link":"https:\/\/www.af-net.eu\/en\/author\/cre8ors\/"},"uagb_comment_info":0,"uagb_excerpt":"The study \"CABA-HFPEF-DZHK27\" (CAtheter-Based\u00a0Ablation of atrial fibrillation vs. conventional treatment in patients with\u00a0Heart\u00a0Failure with\u00a0Preserved\u00a0Ejection\u00a0Fraction) is aiming for\u00a0a better therapy for\u00a0patients with heart failure and atrial fibrillation. Charit\u00e9 (Berlin, Germany) has the overall responsibility\u00a0for the study. This trial is supported by German Centre for Cardiovascular Research\u00a0(DZHK). Further information can be found in the\u00a0press release\u00a0(german only).\u00a0","_links":{"self":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/posts\/10868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/comments?post=10868"}],"version-history":[{"count":2,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/posts\/10868\/revisions"}],"predecessor-version":[{"id":13419,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/posts\/10868\/revisions\/13419"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/media\/11773"}],"wp:attachment":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/media?parent=10868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/categories?post=10868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/tags?post=10868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}